Detalles de la búsqueda
1.
Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease.
Neurology
; 102(5): e208061, 2024 Mar 12.
Artículo
Inglés
| MEDLINE | ID: mdl-38386949
2.
Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer's Disease: A Phase I Clinical Trial.
J Alzheimers Dis Rep
; 7(1): 1015-1024, 2023.
Artículo
Inglés
| MEDLINE | ID: mdl-37849628
3.
Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder.
J Sex Med
; 8(3): 773-82, 2011 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-21091877
4.
Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression.
J Psychiatr Res
; 43(5): 512-8, 2009 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-18707693
5.
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
J Psychiatr Res
; 42(1): 22-34, 2008 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-17445831
6.
A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression.
J Affect Disord
; 108(1-2): 33-41, 2008 May.
Artículo
Inglés
| MEDLINE | ID: mdl-17905442
7.
Implications of pain in generalized anxiety disorder: efficacy of duloxetine.
Prim Care Companion J Clin Psychiatry
; 10(3): 197-204, 2008.
Artículo
Inglés
| MEDLINE | ID: mdl-18615176
8.
Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study.
Eur Psychiatry
; 23(1): 66-73, 2008 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-18164600
9.
Factors influencing depression endpoints research (FINDER): study design and population characteristics.
Eur Psychiatry
; 23(1): 57-65, 2008 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-18086518
10.
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Int Clin Psychopharmacol
; 21(6): 311-7, 2006 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-17012978
11.
Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics.
Int Clin Psychopharmacol
; 21(5): 285-95, 2006 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-16877900
12.
Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies.
Prim Care Companion J Clin Psychiatry
; 8(5): 269-78, 2006.
Artículo
Inglés
| MEDLINE | ID: mdl-17235383
13.
Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary.
Drugs Context
; 2013: 212245, 2013 Jan 03.
Artículo
Inglés
| MEDLINE | ID: mdl-24432034
14.
Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials.
Curr Med Res Opin
; 26(11): 2643-51, 2010 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-20932222
15.
Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial.
J Clin Psychiatry
; 70(5): 706-16, 2009 May.
Artículo
Inglés
| MEDLINE | ID: mdl-19552867
16.
"Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories.
Prim Care Companion J Clin Psychiatry
; 11(6): 307-15, 2009.
Artículo
Inglés
| MEDLINE | ID: mdl-20098522
17.
Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER.
J Affect Disord
; 113(3): 296-302, 2009 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-18603303
18.
Switching to duloxetine from selective serotonin reuptake inhibitor antidepressants: a multicenter trial comparing 2 switching techniques.
J Clin Psychiatry
; 69(1): 95-105, 2008 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-18312043
Resultados
1 -
18
de 18
1
Próxima >
>>